Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Perceptive Advisors LLC's stake in Cytomx Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Perceptive Advisors LLC's stake in Cytomx Therapeutics, Inc. fell to 4.60%, 10,098,824 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
4.60%
Shares
10,098,824
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC4.60%10,098,824
Joseph Edelman4.60%10,098,824
Perceptive Life Sciences Master Fund, Ltd.4.60%10,098,824

Source

View original at SEC

Related